VanEck Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $414M | Sell |
344,960
-94,052
| -21% | -$96.1M | 0.25% | 56 |
|
|
2026
Q1 | $404M | Buy |
439,012
+5,265
| +1% | +$5.34M | 0.3% | 60 |
|
|
2025
Q4 | $466M | Buy |
433,747
+121,698
| +39% | +$116M | 0.39% | 49 |
|
|
2025
Q3 | $238M | Buy |
312,049
+6,260
| +2% | +$4.66M | 0.22% | 97 |
|
|
2025
Q2 | $238M | Buy |
305,789
+35,910
| +13% | +$27.9M | 0.27% | 82 |
|
|
2025
Q1 | $223M | Sell |
269,879
-3,660
| -1% | -$3.05M | 0.29% | 88 |
|
|
2024
Q4 | $211M | Buy |
273,539
+4,070
| +2% | +$3.37M | 0.27% | 91 |
|
|
2024
Q3 | $243M | Buy |
269,469
+28,465
| +12% | +$25.6M | 0.3% | 77 |
|
|
2024
Q2 | $218M | Sell |
241,004
-4,283
| -2% | -$3.43M | 0.31% | 75 |
|
|
2024
Q1 | $191M | Buy |
245,287
+23,286
| +10% | +$16.6M | 0.29% | 96 |
|
|
2023
Q4 | $129M | Buy |
222,001
+12,447
| +6% | +$7.27M | 0.24% | 97 |
|
|
2023
Q3 | $113M | Buy |
209,554
+23,950
| +13% | +$12.3M | 0.25% | 105 |
|
|
2023
Q2 | $87M | Sell |
185,604
-218
| -0.1% | -$91.4K | 0.19% | 116 |
|
|
2023
Q1 | $63.8M | Sell |
185,822
-25,360
| -12% | -$8.55M | 0.15% | 131 |
|
|
2022
Q4 | $77.3M | Sell |
211,182
-6,091
| -3% | -$2.16M | 0.2% | 123 |
|
|
2022
Q3 | $70.3M | Buy |
217,273
+5,781
| +3% | +$1.83M | 0.21% | 119 |
|
|
2022
Q2 | $68.6M | Buy |
211,492
+42,793
| +25% | +$12.8M | 0.18% | 129 |
|
|
2022
Q1 | $48.3M | Buy |
168,699
+1,871
| +1% | +$482K | 0.1% | 179 |
|
|
2021
Q4 | $46.1M | Buy |
166,828
+18,958
| +13% | +$4.81M | 0.11% | 172 |
|
|
2021
Q3 | $34.2M | Buy |
147,870
+16,456
| +13% | +$4.06M | 0.09% | 197 |
|
|
2021
Q2 | $30.2M | Buy |
131,414
+60,930
| +86% | +$12.2M | 0.07% | 215 |
|
|
2021
Q1 | $13.2M | Sell |
70,484
-23,116
| -25% | -$4.52M | 0.04% | 300 |
|
|
2020
Q4 | $15.8M | Buy |
93,600
+4,266
| +5% | +$637K | 0.05% | 233 |
|
|
2020
Q3 | $13.2M | Sell |
89,334
-13,891
| -13% | -$2.15M | 0.04% | 224 |
|
|
2020
Q2 | $16.9M | Sell |
103,225
-43,942
| -30% | -$6.75M | 0.06% | 197 |
|
|
2020
Q1 | $20.4M | Sell |
147,167
-17,809
| -11% | -$2.45M | 0.1% | 142 |
|
|
2019
Q4 | $21.7M | Buy |
164,976
+54,817
| +50% | +$6.35M | 0.08% | 163 |
|
|
2019
Q3 | $12.3M | Sell |
110,159
-5,728
| -5% | -$638K | 0.06% | 201 |
|
|
2019
Q2 | $12.8M | Buy |
115,887
+4,494
| +4% | +$529K | 0.06% | 204 |
|
|
2019
Q1 | $14.5M | Sell |
111,393
-60,224
| -35% | -$7.32M | 0.07% | 189 |
|
|
2018
Q4 | $19.9M | Sell |
171,617
-222,536
| -56% | -$24.9M | 0.1% | 165 |
|
|
2018
Q3 | $42.3M | Sell |
394,153
-243,556
| -38% | -$24.3M | 0.21% | 113 |
|
|
2018
Q2 | $54.4M | Buy |
637,709
+50,207
| +9% | +$4.12M | 0.25% | 93 |
|
|
2018
Q1 | $45.5M | Buy |
587,502
+57,487
| +11% | +$4.63M | 0.23% | 98 |
|
|
2017
Q4 | $44.8M | Sell |
530,015
-16,953
| -3% | -$1.44M | 0.22% | 104 |
|
|
2017
Q3 | $46.8M | Buy |
546,968
+21,939
| +4% | +$1.8M | 0.24% | 87 |
|
|
2017
Q2 | $43.2M | Buy |
525,029
+5,190
| +1% | +$423K | 0.24% | 88 |
|
|
2017
Q1 | $43.7M | Buy |
519,839
+41,442
| +9% | +$3.32M | 0.19% | 99 |
|
|
2016
Q4 | $35.2M | Buy |
478,397
+81,829
| +21% | +$6.09M | 0.18% | 99 |
|
|
2016
Q3 | $31.8M | Sell |
396,568
-10,092
| -2% | -$808K | 0.15% | 98 |
|
|
2016
Q2 | $32M | Buy |
406,660
+241,134
| +146% | +$18.2M | 0.16% | 90 |
|
|
2016
Q1 | $11.9M | Sell |
165,526
-34,816
| -17% | -$2.63M | 0.08% | 160 |
|
|
2015
Q4 | $16.9M | Buy |
200,342
+11,473
| +6% | +$952K | 0.13% | 148 |
|
|
2015
Q3 | $15.8M | Sell |
188,869
-24,531
| -11% | -$2.07M | 0.12% | 142 |
|
|
2015
Q2 | $17.8M | Sell |
213,400
-4,327
| -2% | -$330K | 0.11% | 159 |
|
|
2015
Q1 | $15.8M | Buy |
217,727
+8,832
| +4% | +$629K | 0.09% | 170 |
|
|
2014
Q4 | $14.4M | Sell |
208,895
-60,963
| -23% | -$4.11M | 0.09% | 173 |
|
|
2014
Q3 | $17.5M | Buy |
269,858
+15,017
| +6% | +$951K | 0.09% | 159 |
|
|
2014
Q2 | $15.8M | Buy |
254,841
+15,019
| +6% | +$896K | 0.07% | 161 |
|
|
2014
Q1 | $14.1M | Sell |
239,822
-506,485
| -68% | -$28.3M | 0.07% | 166 |
|
|
2013
Q4 | $38.1M | Buy |
746,307
+541,846
| +265% | +$27.1M | 0.19% | 97 |
|
|
2013
Q3 | $10.3M | Sell |
204,461
-4,736
| -2% | -$248K | 0.05% | 173 |
|
|
2013
Q2 | $10.3M | Buy |
+209,197
| New | +$11.4M | 0.06% | 167 |
|
Other funds holding LLY
VanEck Associates's LLY Position: Q2 2026 in Review
VanEck Associates reduced its Eli Lilly (LLY) stake by 21% in Q2 2026, selling an estimated $96.1M and leaving 344,960 shares worth $414M. The position accounts for 0.25% of the portfolio, ranked #56.
VanEck Associates first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $466M in Q4 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- VanEck Associates held 344,960 shares of Eli Lilly worth $414M as of Q2 2026.
- VanEck Associates sold 94,052 Eli Lilly shares in Q2 2026, an estimated $96.1M.
- Eli Lilly made up 0.25% of VanEck Associates's portfolio in Q2 2026, its #56 holding.
- VanEck Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- VanEck Associates's Eli Lilly position peaked at $466M in Q4 2025.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.